Immunoglobulin replacement therapy reduces chronic rhinosinusitis in patients with antibody deficiency
详细信息 查看全文
- 作者：Jarrett E. Walsh ; Jose G. Gurrola II ; Scott M. Graham ; Sarah L. Mott and Zuhair K Ballas
- 刊名：International Forum of Allergy & Rhinology
- 出版年：2017
- 出版时间：January 2017
- 年：2017
- 卷：7
- 期：1
- 页码：30-36
- 全文大小：674K
- ISSN：2042-6984
文摘
Patients with primary antibody deficiencies have an increased frequency of sinonasal and pulmonary infections. Immunoglobulin (Ig) replacement is a standard therapy for common variable immunodeficiency (CVID) and other antibody deficiency diseases. Although there is convincing evidence that Ig replacement reduces pulmonary infections, there is little evidence that it reduces sinus infections or abates chronic rhinosinusitis (CRS). This study aims to identify the impact of Ig replacement on CRS in antibody deficiencies.